Joel Greenblatt’s INVA Holdings & Trades

First Buy
Q1 2016
Duration Held
39 Quarters
Largest Add
Q2 2017
+489,223 Shares
Current Position
112,746 Shares
$2.06 M Value

Joel Greenblatt's INVA Position Overview

Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 112,746 shares of Innoviva, Inc. (INVA) worth $2.06 M, representing 0.01% of the portfolio. First purchased in 2016-Q1, this long-term strategic position has been held for 39 quarters.

Based on 13F filings, Joel Greenblatt has maintained a strategic position in INVA, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2017, adding 489,223 shares. Largest reduction occurred in Q2 2018, reducing 92,367 shares.

Analysis based on 13F filings available since 2013 Q2

Joel Greenblatt's Innoviva (INVA) Holding Value Over Time

Track share changes against reported price movement

Quarterly Innoviva (INVA) Trades by Joel Greenblatt

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q1 2016 +69,267 New Buy 69,267 $12.59
Q2 2016 -2,876 Reduce 4.15% 66,391 $10.53
Q3 2016 +28,001 Add 42.18% 94,392 $10.99
Q4 2016 -9,104 Reduce 9.64% 85,288 $10.70
Q1 2017 -3,288 Reduce 3.86% 82,000 $13.83
Q2 2017 +489,223 Add 596.61% 571,223 $12.80
Q3 2017 +17,844 Add 3.12% 589,067 $14.12
Q4 2017 -36,312 Reduce 6.16% 552,755 $14.19
Q1 2018 -7,886 Reduce 1.43% 544,869 $16.67
Q2 2018 -92,367 Reduce 16.95% 452,502 $13.80
Q3 2018 -74,040 Reduce 16.36% 378,462 $15.24
Q4 2018 -85,209 Reduce 22.51% 293,253 $17.45
Q1 2019 -65,026 Reduce 22.17% 228,227 $14.03
Q2 2019 -70,332 Reduce 30.82% 157,895 $14.56
Q3 2019 +3,181 Add 2.01% 161,076 $10.54
Q4 2019 -54,142 Reduce 33.61% 106,934 $14.16
Q1 2020 -11,664 Reduce 10.91% 95,270 $11.76
Q2 2020 -37,763 Reduce 39.64% 57,507 $13.98
Q3 2020 +22,621 Add 39.34% 80,128 $10.45
Q4 2020 +3,814 Add 4.76% 83,942 $12.39
Q1 2021 -43,219 Reduce 51.49% 40,723 $11.96
Q2 2021 -5,309 Reduce 13.04% 35,414 $13.41
Q3 2021 +2,975 Add 8.40% 38,389 $16.70
Q4 2021 +17,021 Add 44.34% 55,410 $17.25
Q1 2022 -4,689 Reduce 8.46% 50,721 $19.34
Q2 2022 +9,618 Add 18.96% 60,339 $14.77
Q3 2022 -18,163 Reduce 30.10% 42,176 $11.62
Q4 2022 -2,292 Reduce 5.43% 39,884 $13.25
Q1 2023 -13,140 Reduce 32.95% 26,744 $11.25
Q2 2023 -10,724 Reduce 40.10% 16,020 $12.73
Q3 2023 +2,181 Add 13.61% 18,201 $12.99
Q4 2023 +6,393 Add 35.12% 24,594 $16.04
Q1 2024 +10,370 Add 42.16% 34,964 $15.24
Q2 2024 -4,496 Reduce 12.86% 30,468 $16.40
Q3 2024 +1,519 Add 4.99% 31,987 $19.31
Q4 2024 +11,912 Add 37.24% 43,899 $17.35
Q1 2025 +21,263 Add 48.44% 65,162 $18.13
Q2 2025 +19,244 Add 29.53% 84,406 $20.09
Q3 2025 +28,340 Add 33.58% 112,746 $18.25

Joel Greenblatt's Innoviva Investment FAQs

Joel Greenblatt first purchased Innoviva, Inc. (INVA) in Q1 2016, acquiring 69,267 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Joel Greenblatt has held Innoviva, Inc. (INVA) for 39 quarters since Q1 2016.

Joel Greenblatt's largest addition to Innoviva, Inc. (INVA) was in Q2 2017, adding 571,223 shares worth $7.31 M.

According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 112,746 shares of Innoviva, Inc. (INVA), valued at approximately $2.06 M.

As of the Q3 2025 filing, Innoviva, Inc. (INVA) represents approximately 0.01% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.

Joel Greenblatt's peak holding in Innoviva, Inc. (INVA) was 589,067 shares, as reported at the end of Q3 2017.